FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress
Open Access
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 129, 110439
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Development and Reform Commission ([2011]1570, 2017YFD0501102, 2017YFD0501103-03)
- National Key Research and Development Program of China ([2011]1570, 2017YFD0501102, 2017YFD0501103-03)
This publication has 60 references indexed in Scilit:
- Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetesJournal of Diabetes and its Complications, 2015
- FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight LossCell Metabolism, 2014
- FGF21 regulates metabolism and circadian behavior by acting on the nervous systemNature Medicine, 2013
- AMPK: a nutrient and energy sensor that maintains energy homeostasisNature Reviews Molecular Cell Biology, 2012
- Lithium Suppresses Astrogliogenesis by Neural Stem and Progenitor Cells by Inhibiting STAT3 Pathway Independently of Glycogen Synthase Kinase 3 BetaPLOS ONE, 2011
- Objectively measured physical capability levels and mortality: systematic review and meta-analysisBMJ, 2010
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathwayProceedings of the National Academy of Sciences, 2010
- Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin SensitivityEndocrinology, 2009
- Targeting Cdk5 Activity in Neuronal Degeneration and RegenerationCellular and Molecular Neurobiology, 2009
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009